Skip to content

Edition · Fri · October 23, 2026

October 23, 2026

4 vertical editions · 11 stories · 26 source citations

AI

Artificial intelligence

feed →

Two stories meet the multi-source threshold: the existing OpenAI–PerturbAI research report and BBC reporting on Google staff resignations over military AI contracts. The OpenAI–Google Cloud agreement is omitted because it appeared in the Oct. 22 edition; other collected launches and demos lacked independent follow-up coverage.

BIO

Bio & health

feed →

Two multi-outlet clinical developments qualify: the existing detailed Phase 3 Moderna–Merck melanoma-vaccine results and new Phase 3 topline results for AbbVie’s lutikizumab. CAR-T, peptide-therapy, NAC, and NAD+ candidates in this collection were individual papers or trial-registry records without independent outlet coverage of a clinical or regulatory development.

GEO

Geopolitics & security

feed →

Four developments have independent coverage: the existing Trump–BBC deposition order and North Korea loudspeaker report, plus Ukraine’s account that Starlink limits remained and the Tibet earthquake. Nigeria’s Ebola airport-transmission report had multiple outlets but was excluded as health coverage outside this vertical’s geopolitics and security remit; other collected items lacked a second independent outlet.

MARKETS

Markets & macro

feed →

Three multi-outlet developments qualify: the existing OpenAI financing reports, SK hynix’s decision to halt Solidigm’s IPO review, and Volvo Cars’ Q3 results. Coverage of Moody’s scheduled France rating review was not included because no rating action was available by this edition’s cutoff; other candidates lacked a second independent outlet or relied on unscored social posts.

Type to search

↑↓ navigate ↵ open esc close